Jason Colodne and Colbeck Capital Management Proudly Support the Children’s Tumor Foundation
Colbeck Capital Management, a New York City-based strategic lender, has a history of giving back to the community by supporting charities and non-profit organizations. Jason Colodne, a long-time supporter of the Children’s Tumor Foundation (CTF), tells us that donations are key to enabling the organization’s researchers to develop cures and help children living with neurofibromatosis (NF). Colbeck Capital Management has donated and organized fundraisers on behalf of the Children’s Tumor Foundation via participation in various events, including organizing a cycling team to ride on behalf of the CTF.
The Children’s Tumor Foundation and Neurofibromatosis
Founded in 1978, the Children’s Tumor Foundation began as the first grassroots organization dedicated solely to finding treatments for NF. Today, CTF is the leading force in the fight to end NF, and a model for other innovative research endeavors with a mission to “drive research, expand knowledge, and advance care for the NF community.”
The Children’s Tumor Foundation is a highly recognized 501(c)(3) not-for-profit organization dedicated to finding effective treatments for the millions of people worldwide living with neurofibromatosis, which is a family of three distinct disorders: NF1, NF2, and schwannomatosis. NF causes tumors to grow on nerves throughout the body and may lead to blindness, deafness, bone abnormalities, disfigurement, learning disabilities, disabling pain, and cancer. There is no cure yet – but as the leading organization in the fight to end NF and a model of innovative research endeavors, the Children’s Tumor Foundation’s mission and dedication to the NF community fosters its vision of one day ending NF.
Jason Colodne and Colbeck Capital Management originally became involved with the Children’s Tumor Foundation through his late sister, Bara Colodne, who herself struggled with NF. Bara was an NF Ambassador for the CTF in 2004, and continued to be a volunteer and advocate for the organization throughout her life.
“Bara was incredibly strong and saw NF as a gift. She always said that the disease taught her valuable life lessons,” said Jason Colodne. “Bara left behind a legacy of compassion and strength, and I’m determined to continue supporting the NF community, and specifically CTF, as she did so selflessly during her lifetime.”
About Colbeck Capital Management
Colbeck Capital Management operates offices in Los Angeles and New York City. The company was founded in 2009 by Jason Colodne and Jason Beckman, who still serve as managing partners. Colbeck provides strategic loans to companies going through periods of transition when traditional sources of capital are not readily available.
About Jason Beckman
Jason Beckman attended Union College and The London School of Economics. He spent the early years of his career at Goldman Sachs as the head of Distressed Product Loan Sourcing, Fixed Income Currencies, and Commodities Division. Prior to founding Colbeck, he spent time in the Distressed Group at Deutsche. Beckman co-founded Colbeck in 2009 as a managing partner.
Beckman’s history of philanthropic endeavors includes support for global humanitarian issues through the International Rescue Committee and support for the arts as a benefactor of The Metropolitan Museum of Art and Art Production Fund.
About Jason Colodne
Jason Colodne is a graduate of the University of Pennsylvania. Colodne’s experience in investments spans more than 20 years. Colodne was the head of Proprietary Distressed Investing and the Hybrid Lending Group in the Fixed Income Currencies and Commodities Division at Goldman Sachs. Colodne joined Goldman Sachs after gaining distressed investment and investment banking experience at UBS and Bear Stearns. After working at Goldman Sachs, Colodne was a managing director and the head of the Strategic Finance Division at Morgan Stanley.
In 2009, Jason Colodne co-founded Colbeck Capital Management as a managing partner. In addition to those duties, Colodne is the senior transaction partner at Colbeck and oversees all aspects of investment execution and portfolio management. Colodne is a longtime supporter of the Children’s Tumor Foundation, in addition to his work as a board member of the Centurion Foundation. He is also a member of the Young Professionals Organization – Metro New York.